ORAVESCENT Fentanyl Citrate

DRUG3 trials

Sponsors

Cephalon

Conditions

CancerChronic Low Back PainChronic Neuropathic PainPain

Phase 3

OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients

CompletedNCT00105937

CephalonCancer, Pain

Start: 2004-04-30End: 2006-11-30Target: 300Updated: 2012-06-29

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain

CompletedNCT00214942

CephalonChronic Low Back Pain

Start: 2005-09-30Updated: 2014-05-09

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

CompletedNCT00214955

CephalonChronic Neuropathic Pain

Start: 2005-09-30Target: 120Updated: 2014-05-09